famotidine has been researched along with Malabsorption Syndromes in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Malabsorption Syndromes: General term for a group of MALNUTRITION syndromes caused by failure of normal INTESTINAL ABSORPTION of nutrients.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saunders, DR | 1 |
| Saunders, MD | 1 |
| Sillery, JK | 1 |
1 other study available for famotidine and Malabsorption Syndromes
| Article | Year |
|---|---|
Beneficial effects of glucose polymer and an H2-receptor blocker in a patient with a proximal ileostomy.
Topics: Adult; Carbohydrates; Combined Modality Therapy; Crohn Disease; Famotidine; Fluid Therapy; Histamine | 1989 |